Elevance Health, Inc.

Elevance Health, Inc.

ELVNYSE / NASDAQHealthcareLarge cap

$394.48+$4.32 (+1.1%)

Last close · Data as of Nov 20, 2026

Market cap
$88.9B
P/E
15.7x
Revenue
$199.1B
Net margin
2.8%
ROCE
10.7%

+25.6% over the last year

Elevance Health, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-10.4%
3M
-0.5%
6M
-0.4%
1Y
+25.6%
5Y
-5.0%

52-week range

Day change +$4.32 (+1.1%) from $390 to $394 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in ELV, bought on each weekday since 2021.

News & filings

What Elevance Health filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernOther income of 24.5 billion US dollars was 12% of revenue in fiscal 2025.

Strengths (1)

  • Operating profit was 5.8 times interest costs.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.

Read moreShow less

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Sector
Healthcare
Shares outstanding
220.7M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$88.9B
P/E
15.7x
P/B
2.0x
EV / Sales
0.6x
P/S
0.4x
52-week high
$446.28
52-week low
$280.74

Profitability

Operating margin
4.1%
Net margin
2.8%
ROE
12.9%
ROCE
10.7%
ROA
4.7%
Asset turnover
1.64

Growth

Revenue
$199.1B
Revenue growth, 1Y
12.6%
Revenue CAGR, 3Y
8.3%
Net profit growth, 1Y
-5.3%
Free cash flow
$3.2B

Solvency

Debt / Equity
0.73
Debt / Assets
0.26
CFO / Net profit
0.76
Cash / Market cap
10.7%

Where the revenue went

Some FY2025 lines are not reported, so the ones that are appear as a table.

LineFY2025
Revenue$199.1B
Gross profit$199.1B
Pretax income$6.7B
Tax and other$1.0B
Net income$5.7B

Revenue and net profit

Revenue grew 12.6% in FY2025; net profit is the dashed line.

Elevance Health, Inc. revenue and net profit by fiscal year
Elevance Health, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$156.6B$5.9B
FY2023$171.3B$6.0B
FY2024$176.8B$6.0B
FY2025$199.1B$5.7B

Cash flows

FY2025: $4.3B from operations, $3.2B free after investment (dashed).

Elevance Health, Inc. operating and free cash flow by fiscal year
Elevance Health, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$8.4B$7.2B
FY2023$8.1B$6.8B
FY2024$5.8B$4.6B
FY2025$4.3B$3.2B

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$199.1B+12.6%1Y
Net profit
$5.7B-5.3%1Y
Cash from operations
$4.3B-26.1%1Y
Free cash flow
$3.2B-30.3%1Y
Revenue CAGR, 3Y
8.3%
Net profit CAGR, 3Y
-1.3%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$199.1B—$5.7B$3.2B12.9%+12.6%-5.3%

Monthly returns

Month-by-month returns of ELV across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$121.5B
Liabilities$77.5B
Equity$44.0B
Paid-in capital$8.9B
Retained earnings$35.4B
Minority interest$144.0M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; ELV highlighted.

P/E against peers

ELV trades at 15.7x earnings against a peer median of 20.8x (a 25% discount).

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Elevance Health, Inc.ELVthis companyP/E ↓ discount$88.9B15.7x2.0x12.9%—
Stryker CorporationSYK$115.5B35.6x5.2x14.5%20.2x
Vertex Pharmaceuticals IncorporatedVRTX$112.1B28.4x6.0x21.2%22.4x
Medtronic plcMDT$105.2B22.6x2.2x9.7%14.3x
McKesson CorporationMCK$91.0B19.1x-41.9x-219.2%13.3x
HCA Healthcare, Inc.HCA$80.3B11.8x-13.3x-112.6%8.2x
The Cigna GroupCI$74.2B12.5x1.8x14.3%10.2x
Boston Scientific CorporationBSX$72.6B25.1x3.0x12.0%16.1x
Regeneron Pharmaceuticals, Inc.REGN$65.9B14.6x2.1x14.4%11.3x
Peer median—20.8x2.1x13.1%13.8x

Year-to-date ROI

ELV since 1 January, against earlier years.

Historical volatility

ELV's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

LineFY2025
Operating expenses
Selling, general and administrativeSelling General And Administration—
Other operating expensesOther Operating Expenses$42.2B
Depreciation and amortisationDepreciation And Amortization In Income Statement$628.0M
Amortization$628.0M
Total expensesTotal Expenses$192.4B
Pretax incomePretax Income$6.7B

Learn while you research

Academy chapters picked for Elevance Health, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  3. 03 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  4. 04 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →